72 related articles for article (PubMed ID: 1964919)
1. [Activity and number of lymphocyte beta adrenergic receptors after protracted treatment with mepindolol sulfate of patients with essential arterial hypertension].
Fabris B; De Biasi F; Fischetti F; Leprini R; Castellano M; Carretta R
G Clin Med; 1990 Nov; 71(11):639-44. PubMed ID: 1964919
[TBL] [Abstract][Full Text] [Related]
2. Differential changes in lymphocyte beta 2-adrenoceptor density by beta-blocker administration: role of intrinsic sympathomimetic activity.
Daul A; Wang XL; Borchard U; Bock KD; Brodde OE
J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S93-6. PubMed ID: 2427860
[TBL] [Abstract][Full Text] [Related]
3. [Effect of beta blockers with intrinsic sympathomimetic activity on blood pressure and blood lipids in patients with essential hypertension].
Serro-Azul JB; Wajngarten M; Santomauro A; Braga A; Yazbek Júnior P; Bellotti G; Serro-Azul LG; Pileggi F
Arq Bras Cardiol; 1989 Dec; 53(6):321-5. PubMed ID: 2700113
[TBL] [Abstract][Full Text] [Related]
4. Acute regulation of lymphocyte beta 2-adrenoceptors is altered in patients with essential hypertension.
Brodde OE; Daul AE; O'Hara N; Wang XL; Bock KD
J Hypertens Suppl; 1985 Dec; 3(3):S149-52. PubMed ID: 2856815
[TBL] [Abstract][Full Text] [Related]
5. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
Brodde OE; Daul A; O'Hara N; Bock KD
J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
[TBL] [Abstract][Full Text] [Related]
6. [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension].
Krasnikova TL; Radiukhin VA; Parfenova EV; Suvorov IuI; Ustinova SE
Biull Eksp Biol Med; 1986 Jul; 102(7):46-8. PubMed ID: 2873850
[TBL] [Abstract][Full Text] [Related]
7. Effects of different beta-receptor antagonists on handgrip in essential hypertension.
Fogari R; Marchesi E; Bellomo G; Parini A; Corradi L
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):551-3. PubMed ID: 6129200
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
Man in't Veld AJ; Schalekamp MA
Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
[TBL] [Abstract][Full Text] [Related]
9. Terbutaline-induced desensitization of human lymphocyte beta 2-adrenoceptors. Accelerated restoration of beta-adrenoceptor responsiveness by prednisone and ketotifen.
Brodde OE; Brinkmann M; Schemuth R; O'Hara N; Daul A
J Clin Invest; 1985 Sep; 76(3):1096-101. PubMed ID: 2995446
[TBL] [Abstract][Full Text] [Related]
10. Effects of beta-adrenoceptor antagonist administration on beta 2-adrenoceptor density in human lymphocytes. The role of the "intrinsic sympathomimetic activity".
Brodde OE; Daul A; Stuka N; O'Hara N; Borchard U
Naunyn Schmiedebergs Arch Pharmacol; 1985 Feb; 328(4):417-22. PubMed ID: 2859531
[TBL] [Abstract][Full Text] [Related]
11. The influence of sex, age, blood pressure and physical stress on beta 2-adrenoceptor density of mononuclear cells.
Middeke M; Remien J; Holzgreve H
J Hypertens; 1984 Jun; 2(3):261-4. PubMed ID: 6099387
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological studies on the intrinsic sympathomimetic activity of the beta-adrenoceptor antagonist mepindolol.
Beckmann R; Müller B; Schröder G; Stock G
Arzneimittelforschung; 1986 May; 36(5):811-3. PubMed ID: 2873820
[TBL] [Abstract][Full Text] [Related]
13. Direct 24-hour haemodynamic monitoring after starting beta-blocker therapy: studies with pindolol in hypertension.
v d Meiracker A; Man in't Veld AJ; van Eck HR; Wenting GJ; Schalekamp MA
J Hypertens Suppl; 1984 Dec; 2(3):S581-3. PubMed ID: 6100755
[TBL] [Abstract][Full Text] [Related]
14. Multicenter evaluation of mepindolol and of mepindolol plus hydrochlorothiazide in essential hypertension.
Masoni A; Galassi A; Ginevrino P; Libretti A; Morgagni W; Rappelli A; Tomasi AM
Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):546-50. PubMed ID: 6757152
[TBL] [Abstract][Full Text] [Related]
15. Effect of antihypertensive treatment on the increased beta 2-adrenoceptor density in patients with essential hypertension.
Bono M; Cases A; Calls J; Gaya J; Jiménez W; Carretero J; Rivera F; Revert L
Am J Hypertens; 1995 May; 8(5 Pt 1):487-93. PubMed ID: 7662225
[TBL] [Abstract][Full Text] [Related]
16. Effect of beta-blockers on plasma lipids.
Pasotti C; Zoppi A; Capra A; Rebagliati M; Fogari R
Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):448-52. PubMed ID: 3759280
[TBL] [Abstract][Full Text] [Related]
17. Characteristics of lymphocyte beta-adrenoceptors in essential hypertension: effects of propranolol treatment and dynamic exercise.
Parfyonova EV; Korichneva IL; Suvorov YI; Krasnikova TL
Health Psychol; 1988; 7 Suppl():33-52. PubMed ID: 2854050
[TBL] [Abstract][Full Text] [Related]
18. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
[TBL] [Abstract][Full Text] [Related]
19. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
Hedberg A; Gerber JG; Nies AS; Wolfe BB; Molinoff PB
J Pharmacol Exp Ther; 1986 Oct; 239(1):117-23. PubMed ID: 3020227
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the therapeutic effect of transdermal beta-blocker therapy in patients with essential hypertension.
Spieker C; Vetter W; Zidek W; Vetter H
Arzneimittelforschung; 1989 Nov; 39(11A):1512-4. PubMed ID: 2576202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
